About
Orphan cancer treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (8)
Bryan R. Wood
Eleison Pharmaceuticals
team_member
Edwin J. Thomas
Eleison Pharmaceuticals
team_member
Executive Team
CEO and President
Eleison Pharmaceuticals
executive
Frank Seidman
Eleison Pharmaceuticals
team_member
Joel Morganroth, MD
Eleison Pharmaceuticals
team_member
Matthew Cromie, MS
Vice President, Clinical Research
Eleison Pharmaceuticals
executive
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
547
By Phase
PHASE3: 1PHASE2: 3
By Status
COMPLETED: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT01954992Lead Sponsor
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
PHASE3Recruiting
480 participants
Started: Apr 30, 2014 · Completed: Dec 31, 2026
NCT01650090Lead Sponsor
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
PHASE2Completed
28 participants
Started: Aug 31, 2012 · Completed: Nov 30, 2018
NCT00441467Lead Sponsor
Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma
PHASE2Completed
22 participants
Started: Mar 31, 2007 · Completed: Oct 31, 2008
NCT00442598Lead Sponsor
Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
PHASE2Terminated
17 participants
Started: Jan 31, 2007 · Completed: Apr 30, 2008
Locations (1)
Headquarters
Princeton, NJ, United States
Map
Loading map...